| |
Factors associated with medical resource utilisation and related costs in treatment-experienced patients with genotype 1 chronic hepatitis C virus - SVR "consumes less medical resources"...F3-F4 predicts costs more to treat
|
| |
| |
Reported by Jules Levin
presented at the Viral Hepatitis Congress 2014,
Frankfurt, Germany, 9-11 October 2014
Esse Ifebi Herve Akpo,1 Urbano Sbarigia,2 Joris Kleintjens1
1Deloitte Financial Advisory Services, LLP, Diegem, Belgium; 2Janssen Research and Development, LLC, Beerse, Belgium
|
|
| |
| |
|
|
|
